Trabectedin
| CAS No. | 114899-77-3 | Cat. No. | BCP09790 |
| Name | Trabectedin | ||
| Synonyms | Ecteinascidin-743;Ecteinascidin 743;NSC-684766;NSC 684766;NSC684766;ET-743;ET 743;ET743;Ecteinascidin; | ||
| Formula | C39H43N3O11S | M. Wt | 761.85 |
| Description | Trabectedin is a tetrahydroisoquinoline alkaloid obtained from a Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of soft tissue sarcoma and relapsed ovarian cancer. It has a role as an antineoplastic agent, a marine metabolite, an anti-inflammatory agent and an angiogenesis modulating agent. It is an organic heteropolycyclic compound, an azaspiro compound, an oxaspiro compound, a bridged compound, a lactone, a polyphenol, an acetate ester, a hemiaminal, an organic sulfide, a tertiary amino compound and an isoquinoline alkaloid. | ||
| Pathways | Apoptosis Pathway | ||
| Targets | Apoptosis Inducer | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.